Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
A New Innovative Approach: Application of Digital Healthcare
Posted on August 4th, 2017 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
Just last week, US FDA Commissioner Dr. Scott Gottlieb published a blog on the FDA web site that talks about new policies the FDA is going to be acting upon. These new policies are designed to empower the consumer to act on his own and allow ‘digital healthcare’ technologies to help promote better health. (more…)
Creating a Formula for Precise, Effective Literature Searching
Posted on July 31st, 2017 by Neal Katz in Pharmacovigilance
Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. (more…)
The Link Between Big Pharma and the Supplement Industry
Posted on July 28th, 2017 by Betsy Davis in Pharma R&D
When the FDA updated some of its guidelines around dietary supplements last year, many critics of the supplement (or “nutraceutical”) business were pleased to see a bit more regulation in an industry that enjoys surprisingly little oversight. (more…)
Biosimilars Development & its Future
Posted on July 10th, 2017 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
The pharmaceutical industry had really been quite optimistic as of late regarding regulatory overhaul and getting rid of the ever-present ‘red tape’ within the regulatory body in the US, and the FDA had shown a very positive response towards getting biosimilars approved. (more…)
